Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atara Biotherapeutics (ATRA)
NASDAQ:ATRA
Holding ATRA?
Track your performance easily
Atara Biotherapeutics (ATRA) Ownership Overview
47.05% Insiders
7.44% Mutual Funds
0.70% Other Institutional Investors
3.24% ETFs
41.57% Public Companies and
Individual Investors
The ownership structure of Atara Biotherapeutics (ATRA) stock is a mix of institutional, retail, and individual investors. Approximately 11.38% of the company’s stock is owned by Institutional Investors, 47.05% is owned by Insiders, and 41.57% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 20, 2024 | Anhco Nguyen President & Ceo,director | xxxxxxxxxxxxx | $12059 |
| Aug 20, 2024 | Pascal Touchon President & Ceo,director | xxxxxxxxxxxxx | $20114 |
| Aug 20, 2024 | Jill Henrich Evp, Global Head Ra & Quality | xxxxxxxxxxxxx | $875 |
| Aug 20, 2024 | Eric J Hyllengren Evp, Cfo | xxxxxxxxxxxxx | $7084 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $602556 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 629,608 | Insider | 11.10% | 7,410,486 | |
| 563,325 | Insider | 9.93% | 6,630,335 | |
| 359,000 | Insider | 6.33% | 4,225,430 | |
| 259,000 | Insider | 4.56% | 3,048,430 | |
| 238,500 | Insider | 4.20% | 2,807,145 | |
| 227,500 | Insider | 4.01% | 2,677,675 | |
| 174,731 | Institution | 3.08% | 2,056,584 | |
| 171,284 | Insider | 3.02% | 2,016,013 | |
| 162,882 | Institution | 2.87% | 1,917,121 | |
| 141,924 | Institution | 2.50% | 1,670,445 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 162,882 | Institution | 2.87% | 1,917,121 | |
| 141,924 | Institution | 2.50% | 1,670,445 | |
| 43,962 | Institution | 0.77% | 517,433 | |
| 32,012 | Institution | 0.56% | 376,781 | |
| 14,000 | Institution | 0.25% | 164,780 | |
| 10,318 | Institution | 0.18% | 121,443 | |
| 3,311 | Institution | 0.06% | 38,970 | |
| 2,595 | Institution | 0.05% | 30,543 | |
| 2,403 | Institution | 0.04% | 28,283 | |
| 1,652 | Institution | 0.03% | 19,444 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 120,258 | Institution | 2.12% | 977,698 | |
| 54,473 | Institution | 0.96% | 442,865 | |
| 9,115 | Institution | 0.16% | 103,091 | |
| 364 | Institution | <0.01% | 312 |
FAQ
Who Owns Atara Biotherapeutics (ATRA)?
According to the latest TipRanks data, approximately 0.70% of the company's stock is held by institutional investors, 47.05% is held by insiders, and 41.57% is held by retail investors.
What percentage of Atara Biotherapeutics (ATRA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.70% of Atara Biotherapeutics (ATRA) stock is held by institutional investors.
What percentage of Atara Biotherapeutics (ATRA) stock is held by retail investors?
According to the latest TipRanks data, approximately 41.57% of Atara Biotherapeutics (ATRA) stock is held by retail investors.
Who owns the most shares of Atara Biotherapeutics (ATRA)?
Carol Giltner Gallagher owns the most shares of Atara Biotherapeutics (ATRA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.